Journal September 25, 2026 6 min read

What markers track skin elasticity?

Skin elasticity is tracked through a defined set of biophysical, imaging and biochemical markers. This page sets out the formal names, the measurement instruments named in the trial record, and where the evidence is clin

peptides-pro Editorial

Skin elasticity is assessed through a defined panel of markers rather than a single endpoint. The core biophysical markers are skin elasticity (measured as a deformation or recovery parameter), stratum corneum hydration, wrinkle topography including crow's-feet wrinkle count, dermal thickness and dermal density, radiance and pigmentation. These are read out by named instruments: PRIMOS CR imaging for wrinkle count, and the Corneometer CM 825 for stratum corneum hydration [8]. Alongside these sit biochemical markers of the dermal extracellular matrix — elastin and scaffold-related gene expression, elastase activity, and collagen synthesis by dermal fibroblasts — which are measured in tissue and cell models rather than on the skin surface [2][5].

Synonyms in common use include skin firmness, skin resilience and viscoelasticity; the underlying structural substrate is the elastic fiber network of the dermis, composed of elastin deposited on a scaffold of microfibrillar proteins. The pathway the work centres on is the balance between elastin synthesis and enzymatic degradation by elastase, together with the scaffold protein expression that determines whether newly synthesised elastin is assembled into a functional fiber [2].

Research Studies

Ergothioneine and oxidative-stress biomarkers in healthy adults aged 40 to 65

A randomised, double-blind, placebo-controlled trial is evaluating a branded ergothioneine ingredient in healthy adults aged 40 to 65 years. Participants receive the ingredient or a matching placebo once daily for 12 weeks. The primary objective is the effect on biomarkers associated with oxidative stress and healthy aging; skin elasticity, skin hydration, inflammatory biomarkers and overall safety are secondary objectives [1]. This is a registered protocol; the record does not report results.

Copper tripeptide and multi-target restoration of dermal elastic fibers

Elastic fiber integrity declines during skin aging, particularly photoaging, through increased elastase activity and downregulation of elastin and scaffold-related gene expression. A study investigated a multitarget approach modulating elastin production, elastase activity and scaffold protein expression, and reported findings for copper tripeptide in that model [2]. The work addresses synthesis, degradation and scaffold integrity as separate levers rather than elastin synthesis alone.

Cellbooster Shape and objective skin measurements after injection

A post-market clinical investigation is evaluating a CE-marked, non-crosslinked hyaluronic acid superficial epidermis/dermis injection filler and skinbooster containing L-carnitine and vitamin C, designed for reducing local puffiness by improving microcirculation and hydration. Healthy subjects with signs of facial skin aging receive a 3-session treatment with follow-up over 70 days after the initial injection session, with several objective measurements of skin recorded [3].

NPQ Plus and skin health in a single-arm study of 55 participants

A single-arm, open-label, prospective interventional study evaluated a multi-component nutraceutical containing polyphenols (Oligonol®), nicotinamide mononucleotide (NMN; RevAge®), pyrroloquinoline quinone (PQQ; PureQQ®), coenzyme Q10 and a trace mineral complex. Fifty-five participants with skin concerns consumed one sachet daily for 12 weeks, with assessments at baseline and at Weeks 4 and beyond, covering skin health, antioxidant status, fatigue and self-perceived well-being [4]. The absence of a control arm limits what the design can attribute to the formulation.

Bioactive compounds and fibroblast collagen production in vitro and clinically

Ageing is characterised by declining dermal fibroblast function: reduced proliferative capacity, decreased collagen synthesis and increased oxidative and glycative damage, leading to deterioration of skin elasticity and tissue homeostasis. A study of a dietary supplement containing natural bioactive compounds integrates in vitro and clinical approaches to examine effects on biological processes associated with skin ageing and extracellular matrix integrity [5].

Acetyl hexapeptide-8 and skin permeability in cosmeceutical formulations

Acetyl hexapeptide-8 (AH-8), often described as a "botox-like" peptide, is a biomimetic peptide used in topical formulations intended for anti-aging, scar treatment and skin rejuvenation. A review covers its structure and proposed mechanisms, with particular focus on efficacy and skin permeability [6]. Permeability is the limiting variable for any topically applied peptide, and the review treats it as such.

Oral collagen peptides and skin properties in women aged 35 to 65

A randomised, double-blind, parallel-group trial enrolled 68 healthy women aged 35 to 65 with noticeable facial wrinkles, allocated 1:1 to an active control (n = 34) or a test collagen peptide product (n = 34). One participant in the active control group withdrew for personal reasons and was excluded from the final analysis, leaving 67 participants who completed the study. The trial evaluated whether daily oral intake improved age-associated skin beauty parameters [7].

NatureU® Mind Care BeautyU Caps and 56-day skin-aging parameters

A 56-day, single-centre, open-label, single-arm exploratory study assessed within-participant changes in skin-aging parameters in adult women taking one capsule daily. The primary outcome was change from baseline in crow's-feet wrinkle count at Day 56 by PRIMOS CR imaging; the secondary outcome was change from baseline in stratum corneum hydration at Day 56 by Corneometer CM 825. Exploratory outcomes included other wrinkle topography parameters, skin elasticity, radiance, pigmentation, pore-related parameters, dermal thickness and density, and participant-reported outcomes [8].

Comparison of marker types across the studies above

Marker	Instrument or method	Study population	Source
Crow's-feet wrinkle count	PRIMOS CR imaging	Adult women, 56 days	[8]
Stratum corneum hydration	Corneometer CM 825	Adult women, 56 days	[8]
Skin elasticity, hydration, inflammatory biomarkers	Secondary endpoints, method not specified in record	Healthy adults 40–65, 12 weeks	[1]
Elastin and scaffold gene expression, elastase activity	Tissue and cell model assays	Preclinical model	[2]
Collagen synthesis, fibroblast proliferation	In vitro and clinical	Dermal fibroblasts; clinical arm	[5]

Two reference findings bear on the same marker set without forming the basis of any section above. A randomised controlled study examined a comprehensive topical regimen incorporating niacinamide, Pro-Xylane and panthenol after PicoWay laser, addressing barrier repair and anti-aging outcomes [9]. Separately, a study using a biological knowledge graph and molecular docking screened peptide ingredients for their potential to enhance type III collagen, a collagen subtype associated with skin elasticity and dermal resilience [10]. Two further reference items address delivery rather than markers: interface-engineered supramolecular collagen peptide nanocapsules for barrier repair and matrix remodelling, where transdermal delivery of hydrophilic low-molecular collagen peptides (MW ∼5 kDa) is limited by the stratum corneum barrier [11]; and an integrative in silico and in vitro evaluation of the pentapeptides Vialox and Leuphasyl, in which skin aging drives extracellular matrix degradation, particularly of collagen and elastin [12].

If you are reading this for personal health reasons

The materials described here are sold for laboratory research use only, and we do not provide dosing or medical guidance. Nothing on this page is a recommendation to take any compound. If you are considering a compound for yourself, speak to a licensed clinician.